Cargando…
Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in medical wards remains unknown. Objectives: To evaluate the effects of intermediate-dose vs. standard-dose prophylactic anticoagu...
Autores principales: | Smadja, David M., Bonnet, Guillaume, Gendron, Nicolas, Weizman, Orianne, Khider, Lina, Trimaille, Antonin, Mirault, Tristan, Fauvel, Charles, Diehl, Jean-Luc, Mika, Delphine, Philippe, Aurelien, Pezel, Théo, Goudot, Guillaume, Sutter, Willy, Planquette, Benjamin, Waldmann, Victor, Sanchez, Olivier, Cohen, Ariel, Chocron, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553987/ https://www.ncbi.nlm.nih.gov/pubmed/34722585 http://dx.doi.org/10.3389/fmed.2021.747527 |
Ejemplares similares
-
D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study
por: Chocron, Richard, et al.
Publicado: (2021) -
Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation()
por: Philippe, Aurélien, et al.
Publicado: (2023) -
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID‐19: Insight From a French Multicenter Cohort Study
por: Chocron, Richard, et al.
Publicado: (2021) -
D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak
por: Smadja, David M., et al.
Publicado: (2022) -
Cardiovascular manifestations secondary to COVID-19: A narrative review
por: Fauvel, C., et al.
Publicado: (2022)